By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    The 6 Most Common Injuries Resulting from Motorcycle Accidents
    January 30, 2023
    6 Essential Strategies for Improving Your Medical Practice
    January 25, 2023
    Staying Positive While Living with Mesothelioma
    January 24, 2023
    The Many Health Benefits of Being Outdoors
    January 17, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Obama and Budget Director Certain on Most Facets of ’12 Budget (Just Don’t Ask About Medicare & Medicaid)
    August 23, 2017
    Sweet!! The Secret Branding of Sugar Substitutes
    February 22, 2012
    Is Medicaid Real Insurance?
    September 9, 2017
    Latest News
    Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game
    January 25, 2023
    9 Hospitals That Have Introduced Green Initiatives
    February 1, 2023
    Why a Health Retreat Can Be the Best Medicine
    January 12, 2023
    Best Money-Saving Tips for Health Managers
    January 12, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line
Share
Sign In
Notification Show More
Latest News
struggling with addiction
6 Signs Someone You Know Is Struggling With Addiction
Addiction Addiction Recovery
regrow teeth naturally
Advances in Stem Cell Research Can Help Regrow Teeth Naturally
Dental health
air pollution and cancer
The Proven Links Between Air Pollution and Cancer
News
investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care
prevent birth injuries
Distressing Birth Injuries and How They Can Be Prevented
Women Health
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line
Business

Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line

HerinaAyot
Last updated: 2011/06/14 at 7:20 PM
HerinaAyot
Share
4 Min Read
SHARE

NeoStem (AMEX:NBS) announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received approval for its sixth production line from the Chinese State Food and Drug Administration (SFDA).

NeoStem (AMEX:NBS) announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received approval for its sixth production line from the Chinese State Food and Drug Administration (SFDA).

NeoStem, a pharmaceutical company that focuses on stem cell-based technologies, acquired a 51% interest in China-based Suzhou Eyre, which manufactures and develops generic antibiotics and anti-infective drugs, from China Biopharmaceutical Holdings in October 2009.

The sixth line of production, of which there are two more awaiting approval, will push Suzhou Eyre’s product count to nearly 200 drugs. The line is responsible for 20 finished pharmaceutical products, 80% of which are on the China National Insurance Drug List.

More Read

should nurse practitioner forms an LLC

Should Nurse Practitioners Form an LLC?

Maximizing Outcomes Through Effective Patient Engagement Strategies
How to Take Advantage of Open Enrollment in Medicare
Robotic Technologies Can Improve Hospital Working Conditions
How to Attract More Clients to your Wellness Business

The company’s production lines provided 99% of its $70 million sales in 2010. Its first quarter sales for this year totaled $18 million, a 15% year-over-year increase.

“The Chinese pharmaceutical market, which is the third largest in the world, has estimated sales of over $50 billion for 2011, and is expected to double in the next five years,” said NeoStem CEO Dr. Robin Smith.

According to recent analyst reports, NeoStem, with the assistance of Suzhou Eyre, could see a revenue growth rate of 20% between 2011 and 2013, with the potential to reach $119 million in pharmaceutical sales by 2013.

Indeed, Suzhou Eyre is also in the midst of re-locating to its new 53,000 square foot facility, which it expects will loosen its capacity constraints, improve its productivity and double its capacity.

“Based on the capacity of the new facility, and anticipated volume growth, Erye’s top line revenues should see solid growth in the years ahead and NeoStem’s management will consider our multiple options to realizing the benefits of this increasingly valuable asset,” Smith added.

Aside from its Chinese pharma business, New York-based Neostem has gradually expanded its operations since starting out as a provider of adult stem cell collection and storage services, branching out into cell therapeutics, which is focused on using stem cells to help cure disease.

In January, the company acquired Progenitor, which has cell therapy manufacturing facilities, as well as processing and storage facilities for stem cells collected from the umbilical cord at birth, located on the east and west coast of the US.

Progenitor has performed over 30,000 cell therapy procedures and has processed and stored over 18,000 cell therapy products.

As a result of the acquisition, NeoStem can also now develop stem cell therapies in-house, placing it in a solid position for future growth in the field.

With positive results coming out of China today, NeoStem’s stock jumped almost 5% on the AMEX on Monday, trading at $1.47 per share. –Olivia D’Orazio

Source

 

TAGGED: china, healthcare business

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
HerinaAyot June 14, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Workplace Wellness Meets in the Middle of the Aisle
Next Article Is TV Killing Us?

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

struggling with addiction
6 Signs Someone You Know Is Struggling With Addiction
Addiction Addiction Recovery February 2, 2023
regrow teeth naturally
Advances in Stem Cell Research Can Help Regrow Teeth Naturally
Dental health February 1, 2023
air pollution and cancer
The Proven Links Between Air Pollution and Cancer
News February 1, 2023
investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care January 30, 2023

You Might also Like

green hospitals
Hospital Administration

9 Hospitals That Have Introduced Green Initiatives

January 20, 2023
saving money in healthcare
BusinessGlobal HealthcareHospital Administration

Best Money-Saving Tips for Health Managers

January 12, 2023
HR staff must deal with divisive views in healthcare
BusinessGlobal HealthcareHospital AdministrationPolicy & Law

HR Must Navigate Polarizing Views in Healthcare Workplaces

January 4, 2023
cybersecurity options for hospitals
BusinessHospital Administration

Should Hospitals Use SASE or Traditional Network Security?

January 4, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?